Skip to content

continuance of taking medicine rate to the skin diseases with itching sensation

continuance of taking medicine rate to the skin diseases with itching sensation - continuance of taking medicine rate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000006135
Enrollment
100
Registered
2011-08-15
Start date
2011-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin diseases with itching sensation

Interventions

None listed

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Skin disorder (atopic dermatitis, seborrheic dermatitis, contact dermatitis, hand eczema, hives, prurigo, pruritis, and psoriasis vulgaris and erythema exsudativum multiforme) with itching sensation that anti-histamines of the second generation has indications. 2)At the ambulatory care, the histamine-antagonizing agent's taking is person whom remedial appropriateness and the doctor judge. 3)Person who is experiencing itching now. 4)Person who obtained document and agreement by own free will on full understanding after enough explanation when participating about examination is received.

Exclusion criteria

Exclusion criteria: 1) a person who is treated with oral steroids or the immuno-suppressive agents. 2)Person who has malignant disorder and infectious disease. Person who has possibility of pregnancy. 3)Additionally, person who is judged as improper as included by the doctors.

Design outcomes

Primary

MeasureTime frame
Comparative study of the improvement of VAS (visual analogue scale) evaluation for itching and the number of anti-histamines tablets that the patients forget to take.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026